Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Cancer Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Celgene Corporation
F Hoffmann-La Roche Ltd
Johnson & Johnson
Pfizer Inc
Eli Lilly and Company
Novartis AG
Amgen Inc
Merck & Co, Inc
GlaxoSmithKline Plc
By Type:
Others
Targeted Therapy
Chemotherapy
Immunotherapy
Hormonal Therapy
By Application:
Others
Gastrointestinal
Respiratory/Lung
Breast
Prostate
Blood
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Drug Market Overview 2018-2029
-
1.1 China Cancer Drug Industry Development Overview
-
1.2 China Cancer Drug Industry Development History
-
1.3 China Cancer Drug Industry Market Size (2018-2029)
-
1.4 China Cancer Drug Market Analysis by Type from Production Side
-
1.4.1 China Cancer Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Cancer Drug Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)
-
1.4.3 China Cancer Drug Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)
-
1.4.4 China Cancer Drug Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
1.4.5 China Cancer Drug Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)
-
1.5 China Cancer Drug Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Cancer Drug Sales Volume, Sales Value and Growth Rate of Gastrointestinal (2018-2029)
-
1.5.3 China Cancer Drug Sales Volume, Sales Value and Growth Rate of Respiratory/Lung (2018-2029)
-
1.5.4 China Cancer Drug Sales Volume, Sales Value and Growth Rate of Breast (2018-2029)
-
1.5.5 China Cancer Drug Sales Volume, Sales Value and Growth Rate of Prostate (2018-2029)
-
1.5.6 China Cancer Drug Sales Volume, Sales Value and Growth Rate of Blood (2018-2029)
-
1.6 China Cancer Drug Market Analysis by Region
-
1.6.1 North China Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Drug Industry Development
Chapter 3 Cancer DrugIndustry Chain Analysis
-
3.1 Cancer Drug Industry Chain
-
3.2 Cancer Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Drug Market
-
3.3 Cancer Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Drug Market
Chapter 4 China Cancer Drug Market, by Type
-
4.1 China Cancer Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Drug Production Volume and Growth Rate of Others
-
4.5.2 China Cancer Drug Production Volume and Growth Rate of Targeted Therapy
-
4.5.3 China Cancer Drug Production Volume and Growth Rate of Chemotherapy
-
4.5.4 China Cancer Drug Production Volume and Growth Rate of Immunotherapy
-
4.5.5 China Cancer Drug Production Volume and Growth Rate of Hormonal Therapy
Chapter 5 China Cancer Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Drug Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Drug Market Size and Growth Rate of Others
-
5.5.2 China Cancer Drug Market Size and Growth Rate of Gastrointestinal
-
5.5.3 China Cancer Drug Market Size and Growth Rate of Respiratory/Lung
-
5.5.4 China Cancer Drug Market Size and Growth Rate of Breast
-
5.5.5 China Cancer Drug Market Size and Growth Rate of Prostate
-
5.5.6 China Cancer Drug Market Size and Growth Rate of Blood
Chapter 6 China Cancer Drug Market, by Region
-
6.1 China Cancer Drug Production Volume and Production Value, by Region
-
6.2 China Cancer Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Drug Market Analysis
-
7.1 North China Cancer Drug Market, by Type
-
7.2 North China Cancer Drug Market, by Application
Chapter 8 Central China Cancer Drug Market Analysis
-
8.1 Central China Cancer Drug Market, by Type
-
8.2 Central China Cancer Drug Market, by Application
Chapter 9 South China Cancer Drug Market Analysis
-
9.1 South China Cancer Drug Market, by Type
-
9.2 South China Cancer Drug Market, by Application
Chapter 10 East China Cancer Drug Market Analysis
-
10.1 East China Cancer Drug Market, by Type
-
10.2 East China Cancer Drug Market, by Application
Chapter 11 Northeast China Cancer Drug Market Analysis
-
11.1 Northeast China Cancer Drug Market, by Type
-
11.2 Northeast China Cancer Drug Market, by Application
Chapter 12 Southwest China Cancer Drug Market Analysis
-
12.1 Southwest China Cancer Drug Market, by Type
-
12.2 Southwest China Cancer Drug Market, by Application
Chapter 13 Northwest China Cancer Drug Market Analysis
-
13.1 Northwest China Cancer Drug Market, by Type
-
13.2 Northwest China Cancer Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Celgene Corporation
-
14.1.1 Celgene Corporation Company Profile
-
14.1.2 Celgene Corporation Cancer Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 F Hoffmann-La Roche Ltd
-
14.2.1 F Hoffmann-La Roche Ltd Company Profile
-
14.2.2 F Hoffmann-La Roche Ltd Cancer Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Profile
-
14.3.2 Johnson & Johnson Cancer Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Pfizer Inc
-
14.4.1 Pfizer Inc Company Profile
-
14.4.2 Pfizer Inc Cancer Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Profile
-
14.5.2 Eli Lilly and Company Cancer Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Profile
-
14.6.2 Novartis AG Cancer Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Amgen Inc
-
14.7.1 Amgen Inc Company Profile
-
14.7.2 Amgen Inc Cancer Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Merck & Co, Inc
-
14.8.1 Merck & Co, Inc Company Profile
-
14.8.2 Merck & Co, Inc Cancer Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 GlaxoSmithKline Plc
-
14.9.1 GlaxoSmithKline Plc Company Profile
-
14.9.2 GlaxoSmithKline Plc Cancer Drug Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Drug Industry Research Conclusions
-
15.2 Cancer Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Drug Industry Market Size (2018-2029)
-
Figure China Cancer Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Cancer Drug Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)
-
Figure China Cancer Drug Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)
-
Figure China Cancer Drug Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
Figure China Cancer Drug Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)
-
Figure China Cancer Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Cancer Drug Sales Volume, Sales Value and Growth Rate of Gastrointestinal (2018-2029)
-
Figure China Cancer Drug Sales Volume, Sales Value and Growth Rate of Respiratory/Lung (2018-2029)
-
Figure China Cancer Drug Sales Volume, Sales Value and Growth Rate of Breast (2018-2029)
-
Figure China Cancer Drug Sales Volume, Sales Value and Growth Rate of Prostate (2018-2029)
-
Figure China Cancer Drug Sales Volume, Sales Value and Growth Rate of Blood (2018-2029)
-
Figure North China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Cancer Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Drug Market Share by Type in 2018
-
Figure China Cancer Drug Market Share by Type in 2023
-
Figure China Cancer Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Cancer Drug Production Volume and Growth Rate of Targeted Therapy (2018-2023)
-
Figure China Cancer Drug Production Volume and Growth Rate of Chemotherapy (2018-2023)
-
Figure China Cancer Drug Production Volume and Growth Rate of Immunotherapy (2018-2023)
-
Figure China Cancer Drug Production Volume and Growth Rate of Hormonal Therapy (2018-2023)
-
Figure China Cancer Drug Market Share by Application in 2018
-
Figure China Cancer Drug Market Share by Application in 2023
-
Figure China Cancer Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Drug Market Size and Growth Rate of Others (2018-2023)
-
Figure China Cancer Drug Market Size and Growth Rate of Gastrointestinal (2018-2023)
-
Figure China Cancer Drug Market Size and Growth Rate of Respiratory/Lung (2018-2023)
-
Figure China Cancer Drug Market Size and Growth Rate of Breast (2018-2023)
-
Figure China Cancer Drug Market Size and Growth Rate of Prostate (2018-2023)
-
Figure China Cancer Drug Market Size and Growth Rate of Blood (2018-2023)
-
Table China Cancer Drug Production Volume by Region (2018-2023)
-
Table China Cancer Drug Production Volume Share by Region (2018-2023)
-
Figure China Cancer Drug Production Volume Share by Region (2018-2023)
-
Table China Cancer Drug Production Value by Region (2018-2023)
-
Table China Cancer Drug Production Value Share by Region (2018-2023)
-
Figure China Cancer Drug Production Value Share by Region (2018-2023)
-
Table China Cancer Drug Sales Volume by Region (2018-2023)
-
Table China Cancer Drug Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Drug Sales Volume Share by Region (2018-2023)
-
Table China Cancer Drug Sales Value by Region (2018-2023)
-
Table China Cancer Drug Sales Value Share by Region (2018-2023)
-
Figure China Cancer Drug Sales Value Share by Region (2018-2023)
-
Table North China Cancer Drug Production Volume by Type (2018-2023)
-
Table North China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table North China Cancer Drug Sales Volume by Application (2018-2023)
-
Table North China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Drug Production Volume by Type (2018-2023)
-
Table Central China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Drug Sales Volume by Application (2018-2023)
-
Table Central China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Drug Production Volume by Type (2018-2023)
-
Table South China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table South China Cancer Drug Sales Volume by Application (2018-2023)
-
Table South China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Drug Production Volume by Type (2018-2023)
-
Table East China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table East China Cancer Drug Sales Volume by Application (2018-2023)
-
Table East China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Drug Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Drug Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Drug Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Celgene Corporation Company Profile
-
Table Celgene Corporation Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Plc Company Profile
-
Table GlaxoSmithKline Plc Cancer Drug Revenue, Price and Gross (2018-2023)
-
